CCR

CC chemokine receptor (CCR) antagonists block G protein-coupled receptors that guide leukocyte migration. CCR2, a receptor for monocyte chemoattractant protein 1 (MCP-1), was cloned in 1994 as two splice variants. CCR5 was identified in 1996 as a fusion cofactor for macrophage-tropic human immunodeficiency virus type 1 (HIV-1). Maraviroc, described in 2005 as a selective small-molecule CCR5 inhibitor, blocks this route of viral entry. Other CCR5 antagonists include vicriviroc malate and aplaviroc, while INCB3344 and MK-0812 target CCR2. Cenicriviroc blocks both CCR2 and CCR5, and GSK2239633A is a CCR4 antagonist for studies of T cell trafficking.

Items 151-154 of 154

  • Fosrugocrixan
    Cat. No.
    A64574

    Fosrugocrixan

    Fosrugocrixan is a potent antagonist of the CX3C chemokine receptor 1 (CX3CR1), known for its significant anti-inflammatory effects. By inhibiting CX3CR1, Fosrugocrixan plays a crucial role in studying inflammatory diseases and related pathways. This compound is particularly valuable in research applications focused on chronic inflammatory conditions and immune response modulation.

    Out of stock

    All 3 sizes
  • JMS-17-2 hydrochloride
    Cat. No.
    A64575

    JMS-17-2 hydrochloride

    JMS-17-2 hydrochloride is a potent and selective antagonist of the CX3CR1 receptor, exhibiting an IC50 of 0.32 nM. This compound has been shown to impair metastatic seeding and colonization of breast cancer cells, making it a valuable tool for cancer researchers investigating metastasis and related pathways. Its specificity for CX3CR1 allows for targeted studies in various disease models.

    10 mg
    $805.00
    50 mg
    $3,215.00
    All 2 sizes
  • CX3CR1-IN-2
    Cat. No.
    A64576

    CX3CR1-IN-2

    CX3CR1-IN-2 is a selective inhibitor of CX3CR1, demonstrating an IC50 of 0.04 μM. This compound effectively disrupts the binding of CX3CR1 to its ligand, fractalkine (CX3CL1). CX3CR1-IN-2 is valuable for studying cardiovascular diseases, including heart failure and cardiomyopathy, providing insights into the underlying mechanisms and potential therapeutic targets in these conditions.

    Out of stock

    All 3 sizes
  • CX3CR1-IN-1
    Cat. No.
    A64577

    CX3CR1-IN-1

    CX3CR1-IN-1 is a potent CX3CR1 inhibitor, exhibiting an IC50 of 9 nM. This compound is instrumental in investigating the role of CX3CR1 in various cardiovascular diseases. Its selective inhibition of CX3CR1 allows for elucidation of underlying mechanisms and potential therapeutic strategies in related pathological conditions.

    Out of stock

    All 3 sizes

Items 151-154 of 154

Added to your cart

View Cart Checkout

    Loading...